jRCT1022260005招募中不适用
An exploratory study evaluating the impact of temporalis muscle surgical manipulation on oral function in perioperative neurosurgical patients (TEMP-ORAL Study)
未提供0 个研究点目标入组 30 人开始时间: 待定
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18age 0month 0week old over 至 No limit（—）
- 性别
- All
入选标准
- •Adult patients aged 18 years or older.
- •Patients scheduled to undergo neurosurgical surgery at Fukushima Medical University Hospital or Japanese Red Cross Fukushima Hospital after April
- •Patients able to provide written informed consent before surgery.
排除标准
- •Patients with a history of disease or trauma affecting the oral and maxillofacial region.
- •Patients with dysphagia or swallowing disorders.
- •Patients with cognitive impairment that interferes with study assessments.
- •Patients with diseases causing severe restrictions in nutritional intake (e.g., gastrointestinal obstruction).
- •Patients unable to undergo MRI examination (e.g., pacemaker implantation).
- •Patients considered difficult to follow up (e.g., transfer to another hospital).
研究者
相似试验
招募中
1 期
An exploratory study to investigate the effect of FE 999302 when given together with follitropin delta during controlled ovarian stimulation2023-507630-25-00Ferring Pharmaceuticals A/S600
已完成
1 期
A research study comparing the effect of different dosing conditions on blood levels of semaglutide in a new tablet composition in healthy participantsType 2 Diabetes2023-503949-65-00Novo Nordisk A/S120
招募中
1 期
A study to evaluate the safety and tolerability of single ascending doses of AGMB-101 in healthy participants (Part A) and patients with liver cirrhosis (Part B).2024-515074-26-00AgomAb Therapeutics64
已完成
1 期
A Phase 1 Randomized Study to Evaluate the Effect of Food on the Bioavailability of BMS-986158 in Participants with Advanced Solid Tumors.2023-506661-65-00Bristol-Myers Squibb Services Unlimited Company40
招募中
不适用
Earlier intervention to prevent severe ICANS in Axi-celSevere immune effector cell-associated neurotoxicity syndrome (ICANS)jRCT1041250141335